文献速递

丹麦全国医疗系统中肥厚型与致心律失常性右心室心肌病诊断的地理差异

Geographic variation in the diagnosis of cardiomyopathies in a universal healthcare system: a nationwide study of hypertrophic and arrhythmogenic right ventricular cardiomyopathy in Denmark
RSS 订阅 · Open Heart

这项丹麦全国注册研究纳入截至2024年7月1日诊断为肥厚型心肌病(HCM)或致心律失常性右心室心肌病(ARVC)的个体,按年龄和性别与普通人群1:10匹配。HCM患病率为每10万人71例,ARVC为每10万人8.1例。HCM在不同地区和城乡之间存在显著诊断差异,而ARVC分布较为均匀,提示医疗组织与转诊模式可能影响疾病检出。

要点

  • 丹麦HCM患病率为每10万人71例,ARVC为每10万人8.1例。
  • HCM诊断患病率存在显著地区和城乡差异,首都地区最低。
  • ARVC无显著地区或城乡差异,分布较为均匀。

核心结论

  • 丹麦HCM的诊断患病率存在显著地区和城乡差异,而ARVC分布较为均匀。
  • 医疗组织与转诊模式可能影响HCM的疾病检出差异。

研究设计与样本

  • 丹麦全国注册研究,纳入截至2024年7月1日诊断为HCM或ARVC的全部个体。
  • 按年龄和性别与普通人群进行1:10匹配,数据来自国家注册系统。
  • 市镇按城市化程度进行分类。

主要发现

  • 共识别出4705例个体,其中90%为HCM,10%为ARVC。
  • HCM患病率为每10万人71例,ARVC为每10万人8.1例。
  • 与首都地区相比,所有其他地区的HCM患病率均显著更高。
  • HCM患病率从首都地区的每10万人61.4例到西兰地区的每10万人80.3例不等。
  • HCM在人口稀疏地区的诊断患病率显著高于人口密集地区。

关键数值与推荐

  • HCM患病率:每10万人71例。
  • ARVC患病率:每10万人8.1例。
  • HCM地区患病率范围:每10万人61.4例(首都地区)至80.3例(西兰地区)。

临床怎么用

  • HCM的检出可能受医疗组织和转诊模式影响,需关注地区间诊断可及性差异。
  • ARVC分布均匀,提示现有转诊体系对其识别可能较为一致。

局限性

  • 无法区分诊断患病率差异是源于真实患病率差异还是检出偏倚。
  • 研究基于注册诊断编码,可能存在漏诊或误诊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background In Denmark, hypertrophic cardiomyopathy (HCM) and arrhythmogenic right ventricular cardiomyopathy (ARVC) are primarily diagnosed and managed in specialised inherited cardiac disease clinics, making them suitable for registry-based studies of diagnostic patterns. Both conditions are associated with substantial morbidity, yet nationwide data on prevalence and geographic variation remain limited. We aimed to describe the prevalence and regional distribution of HCM and ARVC in Denmark. Methods In this nationwide registry-based study, we included individuals with a diagnosis of HCM or ARVC in Denmark as of 1 July 2024, matched 1:10 to the general population by age and sex. Data on comorbidities, socioeconomic factors and geographic distribution were obtained from national registries. Municipalities were classified by degree of urbanisation. Results A total of 4705 individuals were identified, of whom 90% had HCM and 10% had ARVC. The prevalence of HCM was 71 per 100 000 individuals, while ARVC prevalence was 8.1 per 100 000. Compared with the Capital Region, all other regions had significantly higher prevalence of HCM, ranging from 61.4 per 100 000 in the Capital Region to 80.3 per 100 000 in Zealand and was significantly higher in thinly populated than densely populated areas. In contrast, ARVC prevalence showed no significant regional variation and no significant urban-rural differences. Socioeconomic characteristics were broadly similar to the general population. Conclusions In Denmark, HCM shows significant geographic and urban-rural variation in diagnosed prevalence, whereas ARVC is more uniformly distributed. These findings suggest that healthcare organisation and referral patterns may contribute to variation in disease detection.

来源:Open Heart,查看原文。版权归原作者所有。

引用

  1. Open Heart:Geographic variation in the diagnosis of cardiomyopathies in a universal healthcare system: a nationwide study of hypertrophic and arrhythmogenic right ventricular cardiomyopathy in Denmark

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。